Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cis-regulatory Sequences02:02

Cis-regulatory Sequences

11.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.2K
4.2K
Sequences01:29

Sequences

309
Sequences are fundamental mathematical objects consisting of ordered lists of numbers that follow a specific rule or pattern. Sequences are critical in various mathematical concepts, including calculus, series, and number theory. They can model real-world phenomena such as population growth, financial investments, and physical processes like the diminishing height of a bouncing ball.Each number in a sequence is referred to as a term. Typically, the terms are denoted as a1, a2, a3,…, where...
309
Sanger Sequencing01:57

Sanger Sequencing

775.2K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
775.2K
Arithmetic Sequences01:30

Arithmetic Sequences

246
An arithmetic sequence is a structured arrangement of numbers where each term is derived by adding a constant value, known as the common difference, to the previous term. This consistent pattern allows for the efficient computation of any term within the sequence as well as the cumulative sum of multiple terms. The formula for finding the nth term of an arithmetic sequence is:Here, aₙ represents the nth term of the sequence, a is the first term, d is the common difference, and n is the...
246
Geometric Sequences01:30

Geometric Sequences

298
In systems where values diminish by a constant proportion at each stage, the resulting sequence follows a geometric structure. Each new value in the sequence is obtained by applying a fixed multiplier to the preceding term. This regular, proportional decline type is often used to represent processes involving gradual loss, such as energy dissipation or reduction in amplitude over time.When analyzing the total effect of such a process across unlimited iterations, the series of values is referred...
298

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.

Blood cancer journal·2026
Same author

ICC/WHO-Defined and NGS-Annotated Idiopathic Hypereosinophilia (iHES/iHE): Mutations, Clinical and Treatment Details, and Predictors of Survival.

American journal of hematology·2026
Same author

Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.

American journal of hematology·2026
Same author

Distinct Longitudinal Patterns of Basal and Squamous Cell Carcinoma in Polycythemia Vera and Essential Thrombocythemia.

American journal of hematology·2026
Same author

<i>CSF3R</i>-mutated chronic neutrophilic leukemia: a two-center study of 44 consecutive patients.

Haematologica·2026
Same author

Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities.

American journal of hematology·2026

Related Experiment Video

Updated: Feb 16, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K

Targeted deep sequencing in primary myelofibrosis.

Ayalew Tefferi1, Terra L Lasho1, Christy M Finke1

  • 1Division of Hematology, Department of Internal Medicine.

Blood Advances
|January 4, 2018
PubMed
Summary

Genetic mutations beyond JAK2/CALR/MPL are common in primary myelofibrosis (PMF) and significantly impact patient survival. Identifying these adverse mutations improves prognostic accuracy for overall and leukemia-free survival in PMF patients.

More Related Videos

Targeted DNA Methylation Analysis by Next-generation Sequencing
08:38

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

38.1K
Unbiased Deep Sequencing of RNA Viruses from Clinical Samples
09:36

Unbiased Deep Sequencing of RNA Viruses from Clinical Samples

Published on: July 2, 2016

17.7K

Related Experiment Videos

Last Updated: Feb 16, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Targeted DNA Methylation Analysis by Next-generation Sequencing
08:38

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

38.1K
Unbiased Deep Sequencing of RNA Viruses from Clinical Samples
09:36

Unbiased Deep Sequencing of RNA Viruses from Clinical Samples

Published on: July 2, 2016

17.7K

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by bone marrow fibrosis.
  • The prognostic significance of genetic mutations, particularly JAK2, CALR, and MPL, is well-established in PMF.
  • However, the role of other genetic variants in PMF prognosis requires further elucidation.

Purpose of the Study:

  • To investigate the prevalence and prognostic impact of DNA sequence variants/mutations other than JAK2/CALR/MPL in patients with PMF.
  • To identify specific adverse mutations and assess their contribution to overall survival (OS) and leukemia-free survival (LFS).
  • To evaluate the combined prognostic value of these additional mutations, independent of existing scoring systems.

Main Methods:

  • Next-generation sequencing (NGS) of a 27-gene panel was performed on bone marrow or whole blood DNA from 182 PMF patients.
  • Age-adjusted multivariable analysis was used to identify adverse variants/mutations impacting OS and LFS.
  • Statistical analyses, including survival curves and hazard ratios, were employed to assess prognostic significance.

Main Results:

  • 81% of patients harbored variants/mutations other than JAK2/CALR/MPL, with ASXL1, TET2, SRSF2, and U2AF1 being most frequent.
  • Adverse variants/mutations (ASXL1, SRSF2, CBL, KIT, RUNX1, SH2B3, CEBPA) were present in 56% of patients and associated with inferior OS (3.6 vs 8.5 years) and LFS (7-year risk, 25% vs 4%).
  • The prognostic impact of these adverse mutations was independent of the Dynamic International Prognostic Scoring System Plus and JAK2/CALR/MPL status, with a significant increase in risk for OS and LFS.

Conclusions:

  • DNA variants/mutations beyond JAK2/CALR/MPL are prevalent in PMF and carry significant prognostic information.
  • The number and specific types of adverse mutations identified provide additional predictive value for overall and leukemia-free survival.
  • These findings underscore the importance of comprehensive genetic profiling for improved risk stratification and management of PMF patients.